OpenVSafe by OpenVAERS
Search V-safe

XTR-49434-70782

4 vaccinations 6 coded responses 26 check-ins 5 free-text entries 0 call cases
Sex
Male
Age at first dose
46-50
ZIP prefix
906 / CA
Registered
2021-07-17
Relationship
Adult relative or friend
Guardian
CTS-15020-69570
Race
American Indian or Alaska Native
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-20
    Dose 1 — Moderna
  2. 2021-04-17
    Dose 2 — Moderna
  3. 2021-07-17
    Registered in v-safe
  4. 2021-12-13
    Dose 3 — Moderna
  5. 2021-12-13
    Health check-in — day 0, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  6. 2021-12-14
    Health check-in — day 7, dose 2, dependent
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  7. 2021-12-14
    Survey response — days 1–6 daily, dose 3, dependent
    MedDRA: Injection site pain — Feeling: Good
    Free text: Sore arm at the injection site
    MedDRA releases: 2024-11 · check-in free text available
  8. 2021-12-17
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  9. 2021-12-19
    Health check-in — days 1–6 daily, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  10. 2021-12-20
    Health check-in — day 7, dose 3, dependent
    Feeling: Good · None
    Adult check-in
  11. 2021-12-27
    Health check-in — day 14, dose 3, dependent
    Feeling: Good
    Adult check-in
  12. 2022-01-04
    Health check-in — day 21, dose 3, dependent
    Feeling: Good
    Adult check-in
  13. 2022-01-10
    Health check-in — day 28, dose 3, dependent
    Feeling: Good
    Adult check-in
  14. 2022-01-17
    Health check-in — day 35, dose 3, dependent
    Feeling: Good
    Adult check-in
  15. 2022-01-24
    Health check-in — day 42, dose 3, dependent
    Feeling: Good
    Adult check-in
  16. 2022-03-14
    Survey response — 3 months, dose 3, dependent
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: A common cold
    MedDRA releases: 2024-11 · check-in free text available
  17. 2022-06-13
    Survey response — 6 months, dose 3, dependent
    MedDRA: Body temperature increased, Cough, Headache, Nasopharyngitis, Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Head cold, coughing, sneezing, runny nose, headache, low fever 99.5
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-11-18
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  19. 2022-11-19
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  20. 2022-11-20
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · Site: Pain · None
    Adult check-in
  21. 2022-11-21
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  22. 2022-11-23
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Good · None
    Adult check-in
  23. 2022-11-24
    Health check-in — days 1–6 daily, dose 4, dependent
    Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  24. 2022-11-26
    Health check-in — day 7, dose 4, dependent
    Feeling: Fair · Fever · Chills, Headache · Be unable to do your normal daily activities
    Adult check-in
  25. 2022-12-02
    Survey response — day 14, dose 4, dependent
    MedDRA: Influenza — Feeling: Good · Be unable to do your normal daily activities
    Free text: Influenza A
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-12-09
    Health check-in — day 21, dose 4, dependent
    Feeling: Good
    Adult check-in
  27. 2022-12-16
    Health check-in — day 28, dose 4, dependent
    Feeling: Good
    Adult check-in
  28. 2022-12-24
    Survey response — day 35, dose 4, dependent
    MedDRA: Nasopharyngitis — Feeling: Fair
    Free text: A mild Head cold
    MedDRA releases: 2024-11 · check-in free text available
  29. 2023-01-01
    Health check-in — day 42, dose 4, dependent
    Feeling: Fair
    Adult check-in
  30. 2023-02-18
  31. 2023-05-21
    Survey response — 6 months, dose 4, dependent
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-20Moderna No
22021-04-17Moderna No
32021-12-13Moderna No
42022-11-18Pfizer-BioNTech Flu

Free text

Release 10 — days 1–6 daily, dose 3, dependent

2021-12-14

Systemic reaction (other): Sore arm at the injection site

Release 11 — 3 months, dose 3, dependent

2022-03-14

Symptoms: A common cold

Release 12 — 6 months, dose 3, dependent

2022-06-13

Symptoms: Head cold, coughing, sneezing, runny nose, headache, low fever 99.5

Release 12 — day 14, dose 4, dependent

2022-12-02

Symptoms: Influenza A

Release 12 — day 35, dose 4, dependent

2022-12-24

Symptoms: A mild Head cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBody temperature increased · · ✓
SDCough · · ✓
SDHeadache · · ✓
SDInfluenza · · ✓
SDNasopharyngitis · · ✓
SDRhinorrhoea · · ✓
SDSneezing · · ✓
SROInjection site pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release